Publications by authors named "Michiko Shindo"

Claim this Profile
H
Hepatic falciform ligament appendagitis evaluated by ultrasound: A report of 2 cases.
Daisuke Miura, Michiko Shindo, Yoshihisa Fukuda

Radiol Case Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Pleural Mesothelioma with Marked Lymphatic Involvement: A Report of Two Autopsy Cases.
Reiko Ideguchi, Kazuto Ashizawa, Saori Akashi, Michiko Shindo, Kazunori Minami

Case Rep Oncol Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment.
Tomoyuki Takashima, Hirayuki Enomoto, Toshiaki Ninomiya, Soo Ryang Kim, Hiroaki Okushin, Michiko Shindo

Hepatol Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
Ahmed El-Shamy, Michiko Shindo, Ikuo Shoji, Lin Deng, Tadao Okuno

Hepatology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy.
Tatsuya Ide, Michio Sata, Kazuaki Chayama, Michiko Shindo, Joji Toyota

Hepatol Int· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection.
Osamu Yokosuka, Koichi Takaguchi, Shinichi Fujioka, Michiko Shindo, Kazuaki Chayama

J Hepatol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.
Michiko Shindo, Kazuaki Chayama, Satoshi Mochida, Joji Toyota, Eiichi Tomita

Hepatol Int· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo interferon system assessed by 2'-5' oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin.
Michiko Shindo, Kazushige Hamada, Teruhisa Morikawa, Yuichi Harano, Tomoaki Nakajima

Hepatol Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A.
Toshitaka Akatsuka, Nobuharu Kobayashi, Takashi Ishikawa, Takafumi Saito, Michiko Shindo

J Autoimmun· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B.
Michiko Shindo, Kazushige Hamada, Akira Muramatsu, Teruhisa Morikawa, Tadao Okuno

J Gastroenterol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
Michiko Shindo, Tadao Okuno

Nihon Rinsho· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Michiko Shindo, Kazushige Hamada, Kenichi Nishioji, Akira Muramatsu, Yoko Oda

J Gastroenterol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic changes in hypervariable region 1 as a possible mechanism for biochemical responders with interferon therapy.
Michiko Shindo, Kazushige Hamada, Yoko Oda, Tadao Okuno

Liver· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis